Picture of CellaVision AB logo

CEVI — CellaVision AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: CellaVision Q3 EBITDA SEK 43 Million

Oct 25 (Reuters) - CellaVision Q3 adjusted EPS SEK 1.09.
* Q3 EBITDA margin 26%
* Q3 pretax profit SEK 32 million
* Q3 sales SEK 168 million

Recent news on CellaVision AB

See all news